Brooks Laboratories Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Selina Ranchal, was filed 31 Aug 2023.
Brooks Laboratories Limited: what insiders have been doing
Every trade that managers of Brooks Laboratories Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. No insider at Brooks Laboratories Limited has published a filing in the past twelve months. The most recent one dates from 15 November 2024.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Since the insiders bought
- +23.1%Entry ₹99.70 · Close at T+365 ₹122.71
- +23.1%Entry ₹99.70 · Close at T+365 ₹122.71
- +23.1%Entry ₹99.70 · Close at T+365 ₹122.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 480,000 shares@ ₹137.40100.0% of flowEquity SharesSEBI:b36574d4c4d7ce272d452e8f8839134dc3030e22
- 115,404 shares@ ₹137.40100.0% of flowEquity SharesSEBI:e76705333bf284441bb26a9cc6c403115da84e98
- 395,011 shares@ ₹136.4066.2% of flowEquity SharesSEBI:7361016fe5153b3980a39a384e44e370e48d1db1
- 200,000 shares@ ₹137.4033.8% of flowEquity SharesSEBI:53b334759ed97bf9ead26638a2a4792ae24a354e
- 46,868 shares@ ₹75.00100.0% of flowEquity SharesSEBI:8b5318a655b1c2b0f319b3d7924cd4ab71b0ce99Canonical exit: 28 Nov 2023 (T+90)
- 4,698 shares@ ₹75.00100.0% of flowEquity SharesSEBI:0f436face1cd7f05bd28d65e079a23741aaca1d7Canonical exit: 28 Nov 2023 (T+90)
- 90,952 shares@ ₹75.00100.0% of flowEquity SharesSEBI:5baaae745d15b852f68e398dd8b57396bd6be4fdCanonical exit: 28 Nov 2023 (T+90)
- 70,970 shares@ ₹75.00100.0% of flowEquity SharesSEBI:38dcf33c2b778f74898baa76c403eb7acc0195a9Canonical exit: 28 Nov 2023 (T+90)
- 70,970 shares@ ₹75.00100.0% of flowEquity SharesSEBI:ff516be05cf79472e3120f38edd95ff7ba6411c7Canonical exit: 28 Nov 2023 (T+90)
9 of 9 declarations
About Brooks Laboratories Limited
Brooks Laboratories Limited is a company focused on the health and pharmaceutical sector. It is listed on the XBOM.
